| Similar Articles |
|---|
 |
Chemistry World
February 2, 2012
Andrew Turley |
AstraZeneca to cut 7300 more jobs UK drugmaker AstraZeneca has announced plans to cut a further 7300 jobs to make annual savings of $1.6 billion by the end of 2014, a move that will cost the company $2.1 billion in the near term.   |
Chemistry World
March 19, 2013
Simon Hadlington |
Global AstraZeneca restructuring will cost 1600 jobs The company's global research blueprint will now be centered on the creation of three 'strategic R&D centers' for small molecules and biologics, to be based in Cambridge in the UK, Gaithersburg in Maryland, US, and Molndal in Sweden, to be completed by 2016. |
Chemistry World
May 7, 2013
Phillip Broadwith |
AstraZeneca site to become biotech hub The first three companies have already moved in, and more will hopefully follow to fill the space left by AZ as it relocates to Cambridge, UK. |
Chemistry World
April 29, 2014
Phillip Broadwith |
Pfizer courts AstraZeneca megamerger US-based pharma behemoth Pfizer has publically announced its intention to make a merger offer to the UK's AstraZeneca, in a deal valued at around $100 billion. |
Chemistry World
February 2008
Nuala Moran |
The Chemistry of Private Equity Private equity has transformed the chemicals industry, but can it play the same role in high-risk R&D driven companies? |
Chemistry World
October 5, 2007
Ananyo Bhattacharya |
UK Government Expected to Strengthen Science The UK government is to launch a 'major campaign' to strengthen school science and overhaul its own science and technology investment. |
Chemistry World
March 8, 2011
Andy Extance |
GSK will pay off UK graduate tuition fees Potential undergraduate chemistry students concerned about their prospects in the face of plant closures and increased tuition fees have been given some cheer by pharmaceutical giant GlaxoSmithKline. |
Chemistry World
December 21, 2015
Phillip Broadwith |
Is bigger really better? Something that's often glossed over in the aftermath of a pharmaceutical mega-merger is whether savings actually materialize, and at what cost to the future success of the businesses. |
Chemistry World
February 2, 2011
Andy Extance |
Pfizer to close historic UK site Most of the 2400 people employed at the Pfizer site in Sandwich, UK, will be made redundant over the next 18-24 months as the US pharma giant restructures its research operations. |
Chemistry World
April 2, 2013
Bibiana Campos Seijo |
More job cuts... The news came in that AstraZeneca is to invest 330 million pounds in a new strategic R&D center and global headquarters in Cambridge, UK. Unfortunately, there is also a negative angle to this story. |
Chemistry World
June 19, 2013
Laura Howes |
AstraZeneca announce new UK hub The new hub will consolidate all of AZ's UK activities, including biologics arm MedImmune, at the Cambridge Biomedical Campus on the southern outskirts of the city. |
Pharmaceutical Executive
December 1, 2011 |
UK Report: Keep Calm and Carry On ... Differently Even as the global economic roller coaster affects one of the country's dearest public institutions, the National Health Service, there is still reason for optimism in these times of austerity. |
Chemistry World
March 2008
Janez Potocnik |
Small is Beautiful The launch of the Enterprise Europe Network should help small and medium enterprises to boost innovation throughout Europe. |
Chemistry World
February 16, 2010
Sean Milmo |
New scheme to boost bio-based chemistry The European Commission has launched an initiative to help chemical companies switch to renewable feedstocks and energy sources. |
Chemistry World
February 6, 2014
Patrick Walter |
Clouds on the horizon for UK science The UK needs to up its game to keep up with the rest of the continent when it comes to science, Europe's research chief has said. |
Chemistry World
July 1, 2014
Emma Stoye |
UK government announces 400m innovation fund The UK government's Technology Strategy Board has set aside 400 million pounds to help companies commercialize new technologies in the 2014 -- 15 financial year. |
